Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Bennett

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Lancet. Infectious Diseases|March 21, 2026
Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trialJames Wassil, Jeff Fairman, Carlos A Fierro, et al.
The Lancet. Infectious Diseases|December 7, 2023
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trialJames Wassil, Maggie Sisti, Jeff Fairman, et al.
Oncoimmunology|June 7, 2018
Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicityLee-Hwa Tai, Almohanad A Alkayyal, Amanda L Leslie, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 6, 2017
The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic reviewSean Bennett, Laura K Baker, Guillaume Martel, et al.
Vaccines|June 28, 2023
A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative AdultsShannon Beaty, Natalie Collins, Nicos Karasavvas, et al.
Abdominal Radiology (New York)|October 31, 2025
Advancing osteoporosis opportunistic screening: multicenter validation of a deep learning algorithm using abdominal CT scansAugusto Sarquis Serpa, Marcelo Straus Takahashi, Eduardo Moreno Júdice de Mattos Farina, et al.
Vaccine|June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trialHennie Geldenhuys, Helen Mearns, David J C Miles, et al.
Vaccine|February 21, 2017
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trialsMaria Norrby, Timo Vesikari, Lars Lindqvist, et al.
BMJ Open|July 17, 2025
Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trialRachel Roke, Erin Lillie, Nick Daneman, et al.
JAMA|August 19, 2024
Tranexamic Acid in Patients Undergoing Liver Resection: The HeLiX Randomized Clinical TrialPaul J Karanicolas, Yulia Lin, Stuart A McCluskey, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Lancet. Infectious Diseases|March 21, 2026
Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trialJames Wassil, Jeff Fairman, Carlos A Fierro, et al.
The Lancet. Infectious Diseases|December 7, 2023
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trialJames Wassil, Maggie Sisti, Jeff Fairman, et al.
Oncoimmunology|June 7, 2018
Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicityLee-Hwa Tai, Almohanad A Alkayyal, Amanda L Leslie, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 6, 2017
The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic reviewSean Bennett, Laura K Baker, Guillaume Martel, et al.
Vaccines|June 28, 2023
A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative AdultsShannon Beaty, Natalie Collins, Nicos Karasavvas, et al.
Abdominal Radiology (New York)|October 31, 2025
Advancing osteoporosis opportunistic screening: multicenter validation of a deep learning algorithm using abdominal CT scansAugusto Sarquis Serpa, Marcelo Straus Takahashi, Eduardo Moreno Júdice de Mattos Farina, et al.
Vaccine|June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trialHennie Geldenhuys, Helen Mearns, David J C Miles, et al.
Vaccine|February 21, 2017
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trialsMaria Norrby, Timo Vesikari, Lars Lindqvist, et al.
BMJ Open|July 17, 2025
Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trialRachel Roke, Erin Lillie, Nick Daneman, et al.
JAMA|August 19, 2024
Tranexamic Acid in Patients Undergoing Liver Resection: The HeLiX Randomized Clinical TrialPaul J Karanicolas, Yulia Lin, Stuart A McCluskey, et al.
Pageof 7